Mitate Zepto Technica proved the world's fastest genetic analysis speed in a simulation of the “RASEN” processor's performance.
May 04, 2021
Mitate Zepto Technica inc. (CEO: Keisuke Harashima) has conducted performance simulations for the “RASEN” processor, which will be installed in a hardware accelerator, Relevant Patent Pending, dedicated to genome analysis under development, and obtained the world's fastest processing results for whole human genome data analysis.
Major reform of Foreign Direct Investment rules in Germany
Apr 30, 2021
“Critical technologies” finally found their way into German FDI rules but start-ups and financial investors may be less burdened than previously assumed.
The long-awaited 17th amendment of the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung - AWV) has now come. It will enter into force on May 1, 2021.
Edinburgh Investment Group Breaks Record Despite Pandemic
Apr 26 2021
Edinburgh-based investment group Par Equity has experienced a record-breaking year, deploying over £17 million of capital between March 2020 and March 2021, up 48% on the same period in the previous year.
ONWARD Completes $32 Million Financing Round
Apr 22, 2021
ONWARD today announced the Company has successfully completed a $32M financing. The round was led by Invest-NL, the Dutch impact investor, and Olympic Investments, the private investment arm of the Onassis Foundation. Several additional new investors and all of ONWARD’s existing investors also participated in the financing, including leading medical technology investors LSP, INKEF Capital, Gimv, and Wellington Partners.
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Apr 21, 2021
NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Chad Rubin has been appointed to the newly created position of Senior Vice President, Corporate Affairs. Mr. Rubin will be responsible for all corporate communications, along with involvement in investor and capital markets activities. He joins NexImmune with more than 20 years of experience in investor relations, investment banking and capital markets within the biotechnology sector.
CAES Gaisler Signs Contract with the European Space Agency for New Advanced Space Processor
April 20, 2021
CAES Gaisler announced today that it has received a contract from the European Space Agency (ESA) to fund the first phase to develop a new advanced processor for space applications. Developed in Sweden and based on the popular LEON5FT Fault Tolerant Processor Core, the GR765 Microprocessor meets market demand for high-performing processors, offering a higher level of integration with more functionality on the chip to reduce weight and keep power consumption low.
Deerfield Management Announces Winners of the First Annual XSeed Award
Apr 20, 2021
Deerfield Management Company, a New York City-based healthcare investment firm, today announced the grant recipients of its XSeed Award, a new program designed to support early-stage life science startups. Each of the five New York City-based award winners, a majority of which were women or other underrepresented founders, will receive a $100,000 grant to further projects focused on infectious diseases.
The 2021 recipients of Deerfield’s inaugural XSeed Award are:
Dr. Chandrabali Ghose-Paul, Founder and CEO of Bioharmony Therapeutics, for her work with next-gen antimicrobial therapies for lethal, drug-resistant bacterial infections
Dr. Ashiwel Undieh, The City College of New York, for his work with platform nanotechnology for enhanced formulation and delivery of mRNA vaccines
Dr. Jonathan Lai, Albert Einstein College of Medicine, for his work with alphavirus-associated arthritis
Dr. Julie Magarian Blander, Professor of Immunology at Weill Cornell Medicine, for her work with pan-coronavirus vaccines
Dr. Andras Fiser, Dr. John Blanchard, Dr. Simone Sidoli, and Dr. Johanna Daily, all from Albert Einstein College of Medicine, for their work to identify effective drug combinations for the treatment of K. pneumoniae
LG Chem to Accelerate the Advancement Into the Promising Carbon Nanotubes Market
Apr 20, 2021
LG Chem (KRX: 051910) has launched the largest Carbon Nanotube (CNT) manufacturing plant in Korea. The company is actively targeting the rapidly growing CNT market, widely used as the material for cathodes in electric vehicle batteries.
TDK Ventures Closes $150 Million Fund for Early-Stage, Materials Science and Hard-Tech Startups
Apr 12, 2021
TDK Corporation (TSE: 6762) announced today that subsidiary TDK Ventures Inc. has closed its second fund, totaling $150 million in new capital. The new fund will primarily target early-stage, global investments in clean technology, advanced materials, industrial, robotics, energy, autonomous vehicles, electric vehicles, and healthtech segments. TDK Ventures’ total assets under management is now $200 million.
Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners
Apr 08, 2021
Based in North Brunswick, NJ, Ascendia Pharmaceuticals, Inc. ("Ascendia") is a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products. The investment was made by Signet Healthcare Partners ("Signet"), a New York-based growth equity firm specializing in healthcare investments. The proceeds will be used to fund Ascendia's facility expansion to support the growing demand in the sector.
France Relance : Aryballe obtient 1,1 millions d’euros pour intensifier ses innovations industrielles en olfaction digitale
Apr 06, 2021
Face à la crise sanitaire du COVID-19, le Ministère de l’Économie, des Finances et de la Relance a débloqué 150 millions d’euros pour soutenir les entreprises les plus innovantes en Régions. Aryballe consacrera cette aide d’état au développement de sa production industrielle sur le territoire national. Sa ligne pilote de pointe produira des capteurs d’odeur miniaturisés, universels et à faible coût, en fort volume. Aryballe pourra ainsi répondre aux besoins mondiaux grandissants en matière d’olfaction digitale, dans l’industrie des arômes et fragrances, et les secteurs de l’automobile et de l’électroménager. L’entreprise iséroise pourra également adresser de nouveaux marchés.
401 Tech Bridge Announces Global Partner to Provide Advanced Materials Capabilities
Apr 01, 2021
Global advanced materials group Haydale has announced that it has partnered with 401 Tech Bridge to provide a HT200 Plasma Reactor and advanced materials support for their innovation ecosystem.
The HT200 Plasma Reactor will be utilized in the 401 Tech Bridge Advanced Materials and Technology Center, managed by the University of Rhode Island (URI), to support material commercialization efforts of Graphene Composites and other local composites and textiles-based businesses.